As diabetes and its consequences are predominantly a result of excessive glucose levels in the bloodstream, a therapy that reduces glucose levels and improves insulin sensitivity while also affecting the pathophysiological pathways implicated in DR would be most useful. This evidence concerns the gene INS and diabetes mellitus.